CAS 1826819-57-1
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 Produkte.
Azintuxizumab
CAS:Azintuxizumab, an IgG4 bispecific antibody, targets BCMA, offering dual-action immunotherapy for relapsed/refractory multiple myeloma in preclinical studies.Reinheit:95% - 97.6% (SDS-PAGE); 96.1% (SEC-HPLC)Farbe und Form:Liquid
